315 related articles for article (PubMed ID: 18037890)
1. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.
Ledgerwood LG; Lal G; Zhang N; Garin A; Esses SJ; Ginhoux F; Merad M; Peche H; Lira SA; Ding Y; Yang Y; He X; Schuchman EH; Allende ML; Ochando JC; Bromberg JS
Nat Immunol; 2008 Jan; 9(1):42-53. PubMed ID: 18037890
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes.
Gorlino CV; Ranocchia RP; Harman MF; García IA; Crespo MI; Morón G; Maletto BA; Pistoresi-Palencia MC
J Immunol; 2014 Aug; 193(4):1966-74. PubMed ID: 25015824
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
4. Reactive murine lymph nodes uniquely permit parenchymal access for T cells that enter via the afferent lymphatics.
Eidsmo L; Stock AT; Heath WR; Bedoui S; Carbone FR
J Pathol; 2012 Apr; 226(5):806-13. PubMed ID: 22170282
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
7. Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin.
Pabst O; Herbrand H; Willenzon S; Worbs T; Schippers A; Müller W; Bernhardt G; Förster R
J Immunol; 2006 Feb; 176(3):1474-80. PubMed ID: 16424175
[TBL] [Abstract][Full Text] [Related]
8. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
[TBL] [Abstract][Full Text] [Related]
9. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
Sensken SC; Nagarajan M; Bode C; Gräler MH
J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
García-Bernal D; Redondo-Muñoz J; Dios-Esponera A; Chèvre R; Bailón E; Garayoa M; Arellano-Sánchez N; Gutierrez NC; Hidalgo A; García-Pardo A; Teixidó J
J Pathol; 2013 Jan; 229(1):36-48. PubMed ID: 22711564
[TBL] [Abstract][Full Text] [Related]
11. The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function.
Davis MD; Kehrl JH
Immunol Res; 2009; 43(1-3):187-97. PubMed ID: 18854957
[TBL] [Abstract][Full Text] [Related]
12. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
von Wenckstern H; Zimmermann K; Kleuser B
Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
[TBL] [Abstract][Full Text] [Related]
13. The opposing forces of shear flow and sphingosine-1-phosphate control marginal zone B cell shuttling.
Tedford K; Steiner M; Koshutin S; Richter K; Tech L; Eggers Y; Jansing I; Schilling K; Hauser AE; Korthals M; Fischer KD
Nat Commun; 2017 Dec; 8(1):2261. PubMed ID: 29273735
[TBL] [Abstract][Full Text] [Related]
14. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.
Sinha RK; Park C; Hwang IY; Davis MD; Kehrl JH
Immunity; 2009 Mar; 30(3):434-46. PubMed ID: 19230723
[TBL] [Abstract][Full Text] [Related]
16. CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration.
Xiong Y; Piao W; Brinkman CC; Li L; Kulinski JM; Olivera A; Cartier A; Hla T; Hippen KL; Blazar BR; Schwab SR; Bromberg JS
Sci Immunol; 2019 Mar; 4(33):. PubMed ID: 30877143
[TBL] [Abstract][Full Text] [Related]
17. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration.
Massberg S; von Andrian UH
N Engl J Med; 2006 Sep; 355(11):1088-91. PubMed ID: 16971715
[No Abstract] [Full Text] [Related]
19. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
Greenwood J; Wang Y; Calder VL
Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
